ABBV vs TSM: Which Is the Better Buy?

Side-by-side comparison of AbbVie Inc. and Taiwan Semiconductor Manufacturing Company Limited — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-29.
AbbVie Inc. · Healthcare
$197.69
+6.3% upside to fair value
Grade C High Quality
VS
Taiwan Semiconductor Manufacturing Company Limited · Technology
$366.24
+45.0% upside to fair value
Grade C High Quality
QuantHub Verdict
TSM has more upside to fair value (+45.0%). TSM trades at a lower forward P/E (27.2x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric ABBV TSM
Current Price $197.69 $366.24
Fair Value Estimate $210.22 $531.05
Upside to Fair Value +6.3% +45.0%
Market Cap $349.7B $1,899.5B
Forward P/E 83.3x 27.2x
EV / EBITDA 23.4x 17.3x
Price / Sales 5.7x 12.8x
Price / FCF 18.7x 51.6x
Revenue Growth YoY +10.0% +36.5%
Gross Margin 70.2% 61.9%
Operating Margin 26.7% 53.2%
Return on Equity -361.6% 36.9%
Dividend Yield 0% 0%
FCF Yield 5.35% 1.94%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
ABBV — AbbVie Inc.
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology, neuroscience, oncology, and aesthetics. The company benefits from a durable competitive moat driven by blockbuster drugs such as Skyrizi and Rinvoq, which are experiencing rapid growth and offsetting declines from Humira due to biosimilar competition. Despite a high trailing and forwa…
TSM — Taiwan Semiconductor Manufacturing Company Limited
Taiwan Semiconductor Manufacturing Company Limited (TSMC) is the world's leading pure-play semiconductor foundry, commanding approximately 60% of the global advanced node foundry market. The company benefits from a durable competitive moat driven by its pioneering foundry model, massive scale, advanced manufacturing capabilities, and strong customer relationships with major technology firms. TSMC…
Accumulation Zones
Metric ABBV TSM
Zone Low $157.66 $398.29
Zone High $178.69 $451.39
In Buy Zone? No Yes
← ABBV Research    TSM Research →    All Research